Plus Therapeutics
PSTV • NASDAQ
Plus Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Marc H. Hedrick, with a market cap of $26.9M.
Market Cap$26.9M
Employees20.0
CEOMarc H. Hedrick
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 29, 2026 · in 2 monthsQ1 2026
Financials
Plus Therapeutics FAQ
Common questions about Plus Therapeutics
Plus Therapeutics is scheduled to report earnings for Q1 2026 on May 29, 2026. Analysts estimate revenue of $960.5K.
Plus Therapeutics has approximately 20 employees.